IDEXX Net Receivables from 2010 to 2024
| 0J8P Stock | 434.17 3.78 0.86% |
Net Receivables | First Reported 1991-06-30 | Previous Quarter 608.3 M | Current Value 587.1 M | Quarterly Volatility 149.7 M |
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 120.7 M, Total Revenue of 3.8 B or Gross Profit of 2.3 B, as well as many indicators such as . IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
IDEXX | Net Receivables |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.